Schedule 13G ownership disclosure
LIMINATUS PHARMA INC.
Common Stock , par value $0.0001 per share · CUSIP: 53271X108
Event date: 2025-04-30
- Filing-level shares
- 1,470,000.00
- Percent of class
- 5.7%
- Nongae Apple Association 1st
Shares: 1,470,000.00 · Class: 5.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-063098
- Form type
- SCHEDULE 13G
- Filer
- Liminatus Pharma, Inc.
- CIK
- CIK 1971387
- Filed
- Jun 26, 2025
- Reporting period
- Apr 30, 2025
- Description
- Schedule 13G beneficial ownership